Acadia: Catalysts Stacking
Summary: The lead drug (Nuplazid) is enjoying aggressive sales growth and thereby trumping competitors. In
Summary: The lead drug (Nuplazid) is enjoying aggressive sales growth and thereby trumping competitors. In
Summary: Acuity is seeing strong sales growth. While gross margins are down, the company is
Summary: Acuity Brands’ top line growth is exceptional, owing to significant acquisitions made last year
Summary: Bright Green Corporation has filed initial information for a direct listing on the Nasdaq